CrypvuCrypto market view
Market data not licensed for redistribution.

GL Pharm Tech

204840 ยท KOSDAQ ยท Household Goods Wholesale

Close
โ€“ Previous close pending (official data.go.kr feed not active yet) Live price โ†—

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)โ€“
PERโ€“
PBRโ€“
ROE %-0.5
Debt ratio % (liabilities / equity)146
Revenue TTM (KRW bn)38.2
Op. profit TTM (KRW bn)0.2
Dividend yield %โ€“

Basis: market cap at โ€ฆ; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

No scheduled risk events found (last checked 2026-10-30 19:40 KST).

See it in the full calendar โ†’

Annual results (KRW bn)

20212022202320242025
Revenue12.416.726.026.035.3
Operating profit-2.7-3.3-3.2-1.80.3
Net income-3.7-0.8-3.7-2.30.0

Quarterly results (KRW bn, 3 months)

2025Q12025Q22025Q32025Q42026Q12026Q2
Revenue7.88.49.59.59.49.7
Operating profit0.10.20.3-0.30.00.2
Net income0.00.10.1-0.2-0.10.1

Largest shareholder

As of the 2025 annual report: ๋”๋ธ”์œ ์‚ฌ์ด์–ธ์Šค์ฃผ์‹ํšŒ์‚ฌ and related parties hold 29.77% of common shares.

Recent disclosures

DateFilingSummary
2026-09-21Single sales/supply contract
[๊ธฐ์žฌ์ •์ •]๋‹จ์ผํŒ๋งคใ†๊ณต๊ธ‰๊ณ„์•ฝ์ฒด๊ฒฐ
DART original
2026-08-21Clinical trial / regulatory approval
ํˆฌ์žํŒ๋‹จ๊ด€๋ จ์ฃผ์š”๊ฒฝ์˜์‚ฌํ•ญ(์ž„์ƒ์‹œํ—˜๊ณ„ํš์Šน์ธ์‹ ์ฒญ๋“ฑ๊ฒฐ์ •) (W2505 ๊ฒฝ๊ตฌ์ œ ์ œ 3์ƒ ์ž„์ƒ์‹œํ—˜๊ณ„ํš(IND) ์Šน์ธ)
DART original
2026-08-13Periodic report (annual/half/quarterly)
๋ฐ˜๊ธฐ๋ณด๊ณ ์„œ (2026.06)
DART original
2026-08-10Trading resumption
์ฃผ๊ถŒ๋งค๋งค๊ฑฐ๋ž˜์ •์ง€ํ•ด์ œ (์•ก๋ฉด๋ณ‘ํ•ฉ ์ฃผ๊ถŒ ๋ณ€๊ฒฝ์ƒ์žฅ)
DART original
2026-08-06Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original
2026-08-06Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-07-31Governance / misc. (routine)
ํ•ฉ๋ณ‘๋“ฑ์ข…๋ฃŒ๋ณด๊ณ ์„œ(ํ•ฉ๋ณ‘)
DART original
2026-07-29Insider / major-holder ownership report
์ฃผ์‹๋“ฑ์˜๋Œ€๋Ÿ‰๋ณด์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ(์ผ๋ฐ˜)
DART original
2026-07-29Insider / major-holder ownership report
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
DART original
2026-07-14Trading halt
์ฃผ๊ถŒ๋งค๋งค๊ฑฐ๋ž˜์ •์ง€ (์ฃผ์‹์˜ ๋ณ‘ํ•ฉ, ๋ถ„ํ•  ๋“ฑ ์ „์ž๋“ฑ๋ก ๋ณ€๊ฒฝ, ๋ง์†Œ)
DART original
2026-07-06Shareholder meeting
์ž„์‹œ์ฃผ์ฃผ์ดํšŒ๊ฒฐ๊ณผ
DART original
2026-06-29Other material event (investment-relevant)
๊ธฐํƒ€๊ฒฝ์˜์‚ฌํ•ญ(์ž์œจ๊ณต์‹œ) (์†Œ๊ทœ๋ชจํ•ฉ๋ณ‘ ์Šน์ธ ์ด์‚ฌํšŒ ๊ฒฐ์˜ ๊ฒฐ๊ณผ ๋ณด๊ณ )
DART original

Past material filings and price reaction (market-adjusted)

DateFiling typeOn the news (vs. market)Next day (vs. market)20 days (vs. market)
2026-08-21Clinical trial / regulatory approval+9.4%-0.8%+5.3%
2026-08-10Trading resumption+9.2%-5.3%+35.2%
2026-07-14Trading halt-2.8%-4.5%-6.2%
2026-06-29Other material event (investment-relevant)-2.5%+1.3%+22.1%
2026-05-28Merger+4.6%+0.9%+3.2%
2026-05-19Stock split / reverse split+1.8%+0.7%+3.1%
2026-02-09Revenue/profit change >=30% (15% large caps)+0.4%-2.9%-5.9%
2025-08-25Unfaithful-disclosure notice+0.3%-1.4%-18.6%
2025-02-11Revenue/profit change >=30% (15% large caps)+1.0%+0.2%-3.5%
2024-03-06Change of largest shareholder-0.6%+2.2%-7.3%
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer โ†’ Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view